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During senescence, Wnt4 expression is down-regulated (unlike their Frizzled receptors),
while PPARgamma expression increases in the thymus. Together, these changes allow
for thymic degeneration to occur, observed as adipose involution. However, when
restored, Wnt4 can efficiently counteract PPARgamma and prevent thymic senescence
from developing. The Wnt-pathway activator miR27b has also been reported to inhibit
PPARgamma. Our goal was to evaluate the Wnt4 and miR27b levels of Wnt4-transgenic
thymic epithelial cell (TEC)-derived exosomes, show their regenerative potential against
age-related thymic degeneration, and visualize their binding and distribution both in
vitro and in vivo. First, transgenic exosomes were harvested from Wnt4 over-expressing
TECs and analyzed by transmission electron microscopy. This unveiled exosomes
ranging from 50 to 100 nm in size. Exosomal Wnt4 protein content was assayed
by ELISA, while miR27b levels were measured by TaqMan qPCR, both showing
elevated levels in transgenic exosomes relative to controls. Of note, kit-purified TEI
(total exosome isolate) outperformed UC (ultracentrifugation)-purified exosomes in these
parameters. In addition, a significant portion of exosomal Wnt4 proved to be displayed
on exosomal surfaces. For functional studies, steroid (Dexamethasone or DX)-induced
TECs were used as cellular aging models in which DX-triggered cellular aging was
efficiently prevented by transgenic exosomes. Finally, DiI lipid-stained exosomes were
applied on the mouse thymus sections and also iv-injected into mice, for in vitro
binding and in vivo tracking, respectively. We have observed distinct staining patterns
using DiI lipid-stained transgenic exosomes on sections of young and aging murine
thymus samples. Moreover, in vivo injected DiI lipid-stained transgenic exosomes
showed detectable homing to the thymus. Of note, Wnt4-transgenic exosome homing
outperformed control (Wnt5a-transgenic) exosome homing. In summary, our findings
indicate that exosomal Wnt4 and miR27b can efficiently counteract thymic adipose
involution. Although extrapolation of mouse results to the human setting needs caution,
our results appoint transgenic TEC exosomes as promising tools of immune rejuvenation
and contribute to the characterization of the immune-modulatory effects of extracellular
vesicles in the context of regenerative medicine.
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INTRODUCTION
Transcription factor FoxN1 is the mastermind of thymus
organogenesis and identity (1), and is also an acknowledged
direct molecular target of the glycolipoprotein Wnt4 (2). As a
consequence, Wnt4 plays a key role during embryonic thymus
development (3, 4) and the maintenance of its identity in
adulthood (5–7). Thymic epithelial cells secrete less Wnt4, while
their Frizzled receptors (Fz4 and Fz6) become up-regulated
indicating a potential compensatory mechanism and possibly
enhanced Wnt4-binding (8). This loss of Wnt4 expression
weakens thymic epithelial identity and allows for thymic adipose
involution to occur (9). This latter process leads to the
expansion of thymic adipose tissue orchestrated by transcription
factor PPARgamma (10). The Wnt/b-catenin pathway and
PPARgamma have been reported to act as mutual inhibitors of
one another in several tissue contexts, including the thymus (11–
13). We have previously shown that the addition of exogenous
Wnt4 reinforces thymic epithelial identity and confers resistance
in a steroid-induced model of senescence through suppressing
PPARgamma (2, 14).
Previous records reported that Wnt4 loses its activity when
purified as a sole compound, but retains activity as supernatant
fraction (15). In harmony, recent publications of various tissue
contexts have suggested that Wnt molecules (including Wnt4)
travel in conjunction with extracellular vesicles (EVs), more
specifically exosomes (12, 16). It has also been reported that a
significant portion of the Wnts—including Wnt4—may actually
be displayed on exosomal surfaces. Along with Wnt4, the Wnt-
pathway activator miR27b has also been shown to specifically
inhibit PPARgamma activity via binding to its promoter region
(17, 18). Similar to theWnts above,miRNA species have also been
suggested to preferentially reside and travel in EVs, especially in
exosomes (19, 20).
EVs are released by most cell types of all phyla and
mediate various biological effects. EVs are classified by their
size where exosomes represent the smallest vesicles with a
diameter of between 30 and 200 nm. Exosomes are produced
by a multi-step process where multi-vesicular bodies (MVBs)
are formed first by cell-membrane invaginations, followed by
the extracellular release of exosomes (21). Biological functions
attributed with exosomes encompass several physiological and
pathological conditions, including cell and tissue regeneration
(22, 23). The thymus epithelium has also been reported
to be a rich source of exosomes with key immunological
relevance (24–26) e.g., in thymocyte selection (25, 27), Yet
to date, TEC (thymic epithelial cell) exosomes have not
been linked with thymus tissue regeneration. Thymus tissue
regeneration is not only relevant for aging studies, but
also in conditions that accelerate thymus degeneration due
to environmental stimuli including specific toxins, viruses,
or heavy metals (28).Due to the reasons above, we have
set out to characterize transgenic exosomes produced by
Wnt4 over-expressing TECs for their Wnt4 and miR27b
content, to test their biological activity in the context of




In vitro experiments were performed using the TEP1 primary-
derived (BALB/c) thymic epithelial cell lines or the A549 human
lung epithelial cell line (A549 served as control producer
cell compared to TEP1). The Wnt4 over-expressing version
of TEP1 and the Wnt5a over-expressing version of A549
were generated via lentiviral transfection linked to the green
fluorescent protein (GFP) as published previously (Wnt5a
served as control compared to Wnt4) (29, 30). Cells were
maintained in DMEM (Dulbecco’s Modified Eagle’s medium,
Lonza) supplemented with 10% FBS (EuroClone), Penicillin-
Streptomycin, L-glutamine, Hepes buffer, non-essential amino
acids (Lonza), and β-mercapto-ethanol (Sigma). In order to
differentiate thymic epithelial cells (TECs) toward adipose,
lineage steroid treatment was used. Dexamethasone (DX) was
diluted from a stock solution of 4 mg/mL to a final concentration
of 1µMas formerly described (10). To counteract the aging effect
of steroid treatment, isolated Wnt4 exosomes were added to the
cell cultures.
Flow-Cytometry
Cell suspensions were prepared from both TEP1 andWnt4 over-
expressing TEP1 cell lines in order to check the presence of Wnt4
over-expression via analyzing the GFP-positive cells. A total of
150,000 cells were collected and washed with 1x PBS (Fisher
BioReagents) then fixed using paraformaldehyde containing
PBS solution. BD FACSCantoTM II flow-cytometer (Becton
Dickinson) was used for data acquisition at a medium flow rate
and stopped at 10,000 events. Measurements were performed and
analyzed with BD FACSDiva Software version 6.1.3.
Exosome Staining, Collection and Isolation
Control mouse TECs(thymic epithelial cells), Wnt4 over-
expressingmouse TECs andWnt5a over-expressing humanA549
cells were cultured in Stemline R© T Cell Expansion Medium
(Merck) and serum-free DMEM (Lonza) until they reached 80–
90% confluence. Serum-free media were used to eliminate the
effect of serum-derived exosomes. Equal volume of FBS-free cell
culture media were collected from T75 tissue culture flasks (TPP)
and centrifuged at 2,000 g for 30min to completely remove cell
debris and apoptotic bodies. Supernatants were filtered through
a 0.45µm filter (Merck Millipore) and incubated overnight at
4◦C having added Total Exosome Isolation Reagent (Invitrogen).
Following a 1 h centrifugation at 10,000 g, pellets were collected
and re-suspended in sterile PBS (GEHealthcare Life Sciences) for
further use. Exosomes were fluorescently-stained using DiI lipid
stain (Invitrogen). DiI lipid-stain was added to the cell culture
medium the day before collecting cell supernatant. DiI lipid-
stain stock solution (50 mg/mL dissolved in DMSO) was diluted
10,000-fold (31).
Transmission Electron Microscopy
Pelleted exosomes were added in 50 µl of PBS onto mesh
grids and dried overnight without the use of any fixative
(32). Contrast staining was performed using uranyl-acetate
and lead-citrate. Exosomes were examined using a Morgagni
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268D transmission electron microscope. Images were acquired
using an integrated MegaView III digital camera (Olympus Soft
Imaging Solutions GmbH).
Immune-Fluorescent Staining
Immune-fluorescent staining was performed on 2-month-
old and 21-month-old mouse thymus cryosections. Seven
micrometer thick tissue sections were mounted onto glass
slides and dried overnight. Tissue samples were fixed with
cold acetone then unspecific protein-protein interactions were
blocked with 5% BSA in PBS solution before applying
fluorochrome-conjugated primary antibodies. FITC-conjugated
a-mouse CD326 (EpCAM) (Clone G8.8, BioLegend) was used at
1:100 dilution and DAPI (1:1,000, Life Technologies) was added
as a nuclear counterstain. Slides were also incubated overnight
with previously DiI-stained Wnt4 exosomes. Following washing
steps with 1x PBS, samples were imaged usingNikon Eclipse Ti-U
microscope equipped with a CCD camera (Andor 4Zyla 5.5) and
FIGURE 1 | Characterization of transgenic exosomes. Flow-cytometric analysis of control (shown in red) and GFP+ Wnt4 over-expressing TECs (thymic epithelial
cells) (shown in green) is presented (A). FITC-A corresponds to FL1 channel where GFP-emitted fluorescence is detected. Please note that FITC-A scale is
logarithmic. Transmission electron micrograph shows TEI exosomes of approx. 50–100 nm in size (B). Wnt4 protein (C) and miR27b RNA (D) levels of TEI (total
exosome isolate) and UC (ultracentrifuged) exosomes are shown as obtained by ELISA and TaqMan qPCR, respectively. From left to right column pairs show level of
over-expression, surface/total content, and TEI/UC content, as applicable. Absolute concentration is shown in ng/ml for Wnt4 (C) and absolute copy number is
shown for miR27b relative to rnu6b (D). Eight (C) and three (D) replicates were used for statistical analysis. Significant differences are shown by asterisks (n/a for not
applicable, ns for not significant, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001) and were calculated using independent samples t-test. For exact numerical values and statistical
analysis please refer to Supplementary Material. Representative drawing of a DiI lipid-stained (red) Wnt4-transgenic exosome showing Wnt4 (surface and internal)
content and miR27b (internal) cargo (E).
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FIGURE 2 | In vitro biological effect of transgenic exosomes. Gene expression
changes of FoxN1, PPARgamma, E-cadherin, N-cadherin, and CIITA are
shown as measured by SYBR-green qPCR following steroid (DX)-treatment
alone (DX, left half of figure), or in combination with transgenic exosomes (DX
+ Wnt4 exo, right half of figure). Three samples of each were used for
statistical analysis. Fold change (relative quantity or RQ) expression is shown,
where RQ = 1 represents baseline control. RQ is relative to control level (left
half of figure), or relative to DX-treatment (right half of figure). Please note that
Y-axis is logarithmic. Significant differences are shown by asterisks (n/a for not
applicable, ns for not significant, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001) and
were calculated using independent samples t-test. For exact numerical values
and statistical analysis please refer to Supplementary Material.
images were captured using NIS-Elements Software. Images were
analyzed using ImageJ Software. Thymus lobes of iv-injected
mice were sectioned to 5µm thickness and the same staining
procedure was used as described above. Staining procedures were
optimized using previous literature data (33–36).
RNA Isolation, cDNA Preparation,
qRT-PCR, TaqMan Array
Total RNAwas isolated using NucleoSpin RNA II Kit (Macherey-
Nagel). High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems) was used for preparation of cDNA to a final
concentration of 1 µg/µL. For qPCR analysis, PikoRealTM Real-
Time PCR System (Thermo Fisher Scientific) was used adding
Luminaris Color HiGreen qPCR Master Mix (Thermo Fisher
Scientific) to the samples. Gene expression was normalized to
mouse β-actin and HPRT housekeeping genes (See Figures 1, 2
for detailed primer list). To detect miR27b levels in exosomes,
Total Exosome RNA & Protein Isolation Kit (Invitrogen) was
used for miRNA isolation. cDNA synthesis was carried out
using High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems) and specific primers for U6B as endogenous control
and miR27b as target gene. Quantification of miR27b was
performed using specific gene targeted TaqManTM MicroRNA
Assay adding TaqMan Universal PCR Master Mix (Applied
Biosystems). Measurements were run on a PikoRealTM Real-Time
PCR System as well using FAM as a fluorophore. Data evaluation
was accomplished using Microsoft Excel.
ELISA
HumanWnt4 ELISA Kit (Merck) was used to measure the Wnt4
protein levels of isolated exosomes. Exosomes isolated fromTEP1
cell culture media were used as controls. We aimed to quantify
surface and total exosome protein levels separately. To detect
surface proteins, pelleted exosomes were dissolved in PBS (for
intact exosomes), while to determine total protein concentration,
exosomes were diluted in Exosome Resuspension Buffer (for
disintegrated exosomes) as suggested by Total Exosome RNA &
Protein Isolation Kit Manual (Invitrogen). Plates were measured
immediately at 450 nm using EnSpire R© Multimode Plate Reader
(PerkinElmer) with its integrated data analysis software. Using
OD values mean absorbance of standards and samples were
calculated and results were analyzed with the help of Microsoft
Excel. Standard curve was plotted and protein concentrations
were calculated in ng/ml. The obtained R2 values showed >0.91
alignment to the standard curve in all cases.
Ultracentrifugation
In order to compare TEI efficiency (37) with standard
ultracentrifugation methods confirming previous literature data
(38, 39), 1ml serum-free medium containing exosomes was
centrifuged at 100,000 g for 3 h at 4◦C (40) using SorvallTM
MTX 150 Micro-Ultracentrifuge (Thermo ScientificTM). Pelleted
exosomes were re-suspended in PBS and used for further
experiments. Protein concentration of ultracentrifuged exosomes
were determined with ELISA and following miRNA isolation,
miR27b levels were assessed by TaqManTM MicroRNA Assay.
In vivo Exosome Homing
Eight week-old BALB/c mice were used for intravenous
introduction of DiI lipid-stained exosomes in a pilot study
(41, 42). For control purpose a mouse received 2 doses of
DiI lipid-stained Wnt5a exosomes diluted in 200 µL of sterile
PBS. Another mouse was injected with the same dosage of DiI
lipid-stained Wnt4 exosomes diluted in 200 µL of sterile PBS.
After 24 h, mice were sacrificed and organs were analyzed for
fluorescent intensity with the help of IVIS Lumina III in vivo
Imaging System. Imaging of the thymus, lungs, liver, and spleen
was performed at 520 nm using Living Image Software. Thymus
lobes were embedded into cryomold and sectioned to confirm
tissue homing. Mice were housed under minimal disease (MD)
conditions and kept in the Laboratory Animal Core Facility of the
University. Experimental procedures were carried out according
to the “1988/XXVIII act of the Hungarian Parliament on Animal
Protection (243/1988)” which complies with recommendations
of the Helsinki Declaration. All animal experiments were
performed with the consent of the Ethics Committee on Animal
Research of the University (ref. no.: #BA02/2000-46/2016).
Statistical Analysis
Statistical analyses were conducted using SPSS version 22.
Descriptive statistics (mean ± SD) were calculated for all data.
Normality was assessed using the Shapiro-Wilk test (n < 50).
Comparisons were performed using one sample t-test and
independent samples t-test. The level of significance was set
at P ≤ 0.05.
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RESULTS
Characterization of Transgenic Exosomes
Stable Wnt over-expressing BALB/c TEC (thymic epithelial cell)
lines have been generated using lentiviral vectors as described
previously (30). In the current setting, we focused on the
characterization of exosomes secreted by the transgenic cell
lines. Purity and transgenic status of cell lines was confirmed by
GFP expression provided by the same bicistronic construct that
also drives Wnt secretion. Flow-cytometric analysis verified that
the transgenic cells express GFP and hence secrete Wnt4 at a
uniform level (see Figure 1A). TECs have been reported to be
rich EV and exosome sources. Using a commercially available
PEG-based kit (40) we then enriched transgenic exosomes (TEI:
total exosome isolate) from TEC line supernatant. The enriched
supernatant fraction was confirmed by transmission electron
microscopy to contain of uniform-sized exosomes of approx.
50–100 nm in diameter (see Figure 1B). Along with Wnt4,
the Wnt-pathway activator miR27b has also been reported to
suppress PPARgamma (17, 18, 43, 44). For this reason, we
have measured both Wnt4 protein and miR27b RNA quantities
in transgenic exosomes relative to their control counterparts,
using ELISA and TaqMan qPCR methods, respectively. As
expected, both Wnt4 and miR27b showed elevated and
statistically significant levels in exosomes of transgenic TECs
compared to their control counterparts (see Figures 1C,D).
Furthermore, we have measured total Wnt4 concentration (via
lysis of exosomes) and surface Wnt4 concentration (using intact
exosomes) showing that a significant portion of Wnt4 is surface-
displayed, in harmony with literature (8, 19) (Figure 1C). Of
note, UC (ultracentrifugation) has repeatedly provided poor
exosomal protein and miRNA yield as compared to TEI
(see Figures 1C,D). Figure 1E shows schematic drawing of
DiI lipid-stained transgenic exosome with Wnt4 content and
miR27b cargo.
Biological Effect of Transgenic Exosomes
We have previously reported that the supernatant of the
Wnt4 over-expressing BALB/c TEC (thymic epithelial cell)
line confers resistance to steroid (Dexamethasone or DX)-
induced accelerated aging in our cellular model system (2). In
short, DX-treatment triggers adipose transformation of TECs
via epithelial-to-mesenchymal transition (EMT) (10). We have
used the same experimental setting using enriched transgenic
exosomes instead of transgenic supernatant. As expected and
shown by SYBR-green qPCR (see Figure 2), the applied DX-
treatment triggers loss of TEC identity (decreased FoxN1 and
MHCII or CIITA expression), promotes EMT (cadherin switch
or decreased E-cadherin and increased N-cadherin expression),
and initiates adipose transformation (increased PPARgamma
expression). In perfect conformity with our previous reports
using transgenic supernatant (2, 4), the transgenic exosomes
FIGURE 3 | In vitro binding and distribution of transgenic exosomes. Frozen mouse thymic sections from young adult (2 months, A) and senior adult (21 months, B)
are shown. Sections were labeled using EpCAM1-FITC (shown in green). Transgenic exosomes were pre-stained using DiI lipid stain (shown in red). Representative
slide is presented. Data were calculated using five slides each. Integrated pixel density values are shown for EpCAM1 (shown in green) and DiI lipid stain (shown in red)
(C). Significant differences are shown by asterisks (n/a for not applicable, ns for not significant, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001) as obtained using independent
sample t-test. Data were calculated using five slides each. For exact numerical values and standard deviation please refer to Supplementary Material.
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also efficiently counteract all of the above gene expressional
changes, preserving TEC identity, blocking EMT, and adipose
transformation from developing.
In vitro Binding and Distribution of
Transgenic Exosomes
We have shown above that our transgenic exosomes harbor
elevated amounts of Wnt4 of which a significant portion is
surface-displayed. Previously we have reported that Wnt4-
binding Frizzled receptors (Fz4 and Fz6) are up-regulated in
aged TECs (thymic epithelial cells) as compared to young
TECs (8). Next, we have tested whether thymic histological
sections can bind transgenic exosomes using standard immune-
fluorescent staining protocol. We were also interested to see
if histological in vitro binding shows a particular pattern
and furthermore, if this pattern changes with the age of the
epithelium as suggested by Frizzled up-regulation (2, 8). For
this reason, DiI lipid-stained transgenic exosomes have been
applied on thymic sections of mice of 2-month-old (young) and
21-month-old (aged) for histological staining. As anticipated,
both young and old mouse thymic sections efficiently bind
transgenic exosomes (see Figures 3A,B, respectively). Relative
to the histological presentation of the EpCAM-1++ medullary
epithelium, the transgenic exosomes showed preferential binding
tomedullary regions at a young age (see Figure 3A), while a more
profound cortical binding pattern was observed at an old age
(see Figure 3B). Not only does the binding pattern change with
age (shifting from medullary at a young age to cortical at an old
age), but binding efficiency also increases with age (observed as
increased, statistically significant DiI/fluorescent integrated pixel
density at old age compared to young age, see Figure 3C). Please
also note that themedullary area shrinks with age relative to other
areas, in harmony with our previous records (4) observed here as
mild indicative decrease of FITC integrated pixel density at old
age compared to young age (see Figure 3C).
In vivo Binding and Distribution of
Transgenic Exosomes
The thymic epithelium has been reported to be highly active in
exosome trafficking (24, 25, 45). We have shown above that our
Wnt4-transgenic exosomes readily bind to the thymic epithelium
in vitro on histological sections. However, we were interested
to see if in vivo binding of transgenic exosomes also occurs
in the thymic epithelium. For this reason, DiI lipid-stained
Wnt5a-transgenic (serving as control) human (A549), andWn4-
transgenic (serving as sample) BALB/c (TEP1) exosomes have
been injected into tail veins of young adult BALB/c mice to
check their in vivo topological distribution after 24 h. It has
been reported that certain organs (e.g., liver, lungs, and spleen)
capture a significant portion of exosomes rapidly and non-
specifically following systemic administration (46). Using IVIS
Lumina III imaging and performing topological reconstruction
of murine organs over standard mouse contour, we were able to
record detectable homing of transgenic exosomes to the thymus
despite significant non-specific capture by other organs (e.g.,
liver, lungs, and spleen) (see Figure 4A). Fluorescent signals of
DiI lipid-stained sampleWnt4-transgenic TEC (thymic epithelial
cell) exosomes exceeded control values of Wnt5a-transgenic
exosomes (see Figure 4B). It is worthy of note that thymic signals
exceed pulmonary and splenic signals, despite significant size
differences. Furthermore, immune-fluorescently labeled sections
of the in vivo Wnt4-transgenic exosome-infiltrated thymus
revealed the histological level homing pattern observed after 24 h
(see Figures 5A,B) that allows for the quantitative evaluation of
transgenic exosome homing (see Figure 5C).
DISCUSSION
In harmony with literature data, our results confirm that
the thymic epithelium is a particularly rich source of EVs
and exosomes (24, 25, 45). The Wnt4 over-expressing
transgenic TEC (thymic epithelial cell) line proves to be
a reliable source of transgenic exosomes that are easy to
visualize, enrich to high purity, characterize, and apply in
experiments. As anticipated, the transgenic exosomes contain
elevated levels of Wnt4 protein, as well as the Wnt-pathway
activator miR27b, which potentially synergizes with Wnt4 to
counteract PPARgamma.
Based on our current results obtained with our thymus aging
cellular model system the transgenic exosomes transmit the
biological activity that was previously attributed to supernatant
transfer (2, 4). The applied transgenic exosomes efficiently
prevent steroid-triggered adipose transformation as supported
by reinforced epithelial identity (increased FoxN1 and CIITA
expression), lack of EMT (sustained E-cadherin and low N-
cadherin expression) and resistance to adipose differentiation
(low PPARgamma expression) in line with our previous reports
using transgenic supernatants.
Histological level analysis of in vitro transgenic exosome
binding provides information in more depth. At a young age
(2-month-), transgenic exosomes readily bind to the thymic
epithelium with slight medullary preference. In contrast, at an
old age (21-month-), transgenic exosomes show a moderate
cortical preference. Furthermore, transgenic exosomes show
significantly higher overall binding frequency at an old age,
suggesting that the senescent thymic epithelium readily adsorbs
Wnt4-transgenic exosomes. This is supported by literature
data and our own results showing that a significant portion of
exosomal Wnt4 is surface-displayed and that Wnt4-binding
Frizzled receptors (Fz4 and Fz6) are up-regulated in senescent
TECs (8). Combined, our previous and current results suggest
that as Wnt4 secretion decreases with age and since cortical
areas show preferential binding of the remaining Wnt4 (a key
factor of TEC identity) at an old age, age-related medullary
involution may precede cortical involution due to the medullary
lack of Wnt4-effect (10, 14, 47). To our knowledge, this is a novel
molecular level explanation of accelerated medullary involution.
Highlighting the relevance of our in vitro binding assay, our
in vivo transgenic exosome homing assay shows detectable
homing to the thymus when using mouse TEC-derived Wnt4-
transgenic exosomes as opposed to control exosomes (human
A549-derived Wnt5a-transgenic exosomes). Histological
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FIGURE 4 | In vivo binding and distribution of transgenic exosomes. DiI lipid-stained and iv-injected exosomes show differential topological distribution patterns
(radiant efficiency) after 24 h. Organotopic distribution was reconstructed using standard mouse contour. The thymus, lungs, spleen, and liver were analyzed using
IVIS Lumina imaging (A). Radiant efficiency of thymus relative to liver (RQ) is shown for of DiI lipid-stained and iv-injected transgenic exosomes after 24 h for Wnt5a
(control) and Wnt4 (sample) (B). Significant differences are shown by asterisks (n/a for not applicable, ns for not significant, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001) as
obtained using independent samples t-test. Pilot study is shown. For exact numerical values please refer to Supplementary Material.
FIGURE 5 | Ex vivo binding and distribution of transgenic exosomes. Frozen mouse thymic sections from control (A) and DiI lipid-stained Wnt4-transgenic exosome
iv-injected mouse (B) are shown 24 h after administration. Sections were stained for EpCAM1-FITC (shown in green). Transgenic exosomes were pre-stained using DiI
lipid stain (shown in red). DAPI was used as nuclear counter-stain (shown in blue). Integrated pixel density values are shown for EpCAM1 (shown in green) and DiI lipid
stain (shown in red) (C). Significant differences are shown by asterisks (n/a for not applicable, ns for not significant, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001) as obtained
using independent samples t-test. Pilot study is shown. For exact numerical values please refer to Supplementary Material.
analysis of Wnt4-transgenic exosome-infiltrated thymus sections
confirms their presence also showing distribution pattern and
binding frequency.
In summary, based on our cellular aging model system,
along with in vitro and in vivo binding and homing studies,
respectively; our results confirm that transgenic exosomes
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readily and efficiently provide a permissive niche for immune
regeneration in the mouse setting and hold promise for human
application as well.
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